Product catalog
contact us
    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Enterprise email:bd@kcibiotech.com
    BD contact information:
    North China:Mr. Xiong 15339988450
    East and South China:Ms. Gu 15378638068
    East China:Mr. Hou 13185096531
    Central and Western regions: Ms. Xiang 15828112963
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key Models for Deep Vein Thrombosis Drug Development

  Deep vein thrombosis (DVT) is the abnormal clotting of blood in the deep veins and is a disorder of venous return in the lower extremities. Most of the thrombosis occurs in the state of braking (especially major orthopedic surgery). If not diagnosed and treated in time, most of them will evolve into sequelae of thrombosis, which will affect the quality of life of patients for a long time; and some patients may have pulmonary embolism, which will cause extremely serious consequences.
  We have established a stable vena cava thrombosis model, which is suitable for preclinical research and new drug evaluation of drugs for treating venous thrombosis.
    If you have a project need and experience more of our professional services, please contact us.

Our Services

Disease name

Model name

Animal species

Deep vein thrombosis Model of inferior vena cava thrombosis caused by transient blood flow occlusion mouse,rat,rabbit
Thrombin-induced thrombus model of the inferior vena cava mouse,rat,rabbit
Femoral vein thrombosis model mouse,rat,rabbit
Collagen + epinephrine - induced a pulmonary artery thrombosis model mouse
Thrombin - induced pulmonary artery thrombosis model mouse
ADP - induced pulmonary artery thrombosis model mouse

Case sharing

Balloon catheter therapy for deep vein thrombosis (DVT) in New Zealand rabbits






Previous:Hypertension
Next:Arterial thrombosis